Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
Mangalam Drugs&Org.
|
Vilin Bio Med
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 1.78 % | 3.09 % |
|
5yr average Equity Multiplier
|
1.42 | 2.43 | 1.6 |
|
5yr Average Asset Turnover Ratio
|
0.08 | 1.0 | 0.68 |
|
5yr Avg Net Profit Margin
|
-205.63 % | 0.0 | 2.8 % |
|
Price to Book
|
1.1 | 0.38 | 0.0 |
|
P/E
|
0.0 | 0.0 | 210.97 |
|
5yr Avg Cash Conversion Cycle
|
124.89 Days | 17.41 Days | 211.9 Days |
|
Inventory Days
|
3040.44 Days | 132.58 Days | 70.76 Days |
|
Days Receivable
|
137.33 Days | 38.43 Days | 147.75 Days |
|
Days Payable
|
1845.08 Days | 126.53 Days | 44.01 Days |
|
5yr Average Interest Coverage Ratio
|
-2.88 | 0.9 | 1.77 |
|
5yr Avg ROCE
|
-8.17 % | 6.92 % | 8.99 % |
|
5yr Avg Operating Profit Margin
|
-192.46 % | 7.63 % | 9.07 % |
|
5 yr average Debt to Equity
|
0.26 | 0.59 | 0.47 |
|
5yr CAGR Net Profit
|
19.73 % | 39.54 % | 12.89 % |
|
5yr Average Return on Assets
|
-6.49 % | -0.18 % | 1.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 35.65 % | 59.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | -14.67 % | -4.95 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
Mangalam Drugs&Org.
|
Vilin Bio Med
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|